Renaissance Technologies
ETNB

Renaissance Technologies’s 89bio ETNB Stock Holding History

Renaissance Technologies’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-510,500
Closed -$7.5M – 3384
2025
Q3 		$7.5M Sell
510,500
-2,900
-0.6% -$29.6K 0.01% 1241
2025
Q2 		$5.04M Buy
513,400
+9,100
+2% +$75.3K 0.01% 1525
2025
Q1 		$3.67M Buy
504,300
+206,600
+69% +$1.81M 0.01% 1611
2024
Q4 		$2.33M Sell
297,700
-14,324
-5% -$118K ﹤0.01% 1959
2024
Q3 		$2.31M Buy
312,024
+32,624
+12% +$274K ﹤0.01% 1926
2024
Q2 		$2.24M Buy
+279,400
New +$2.49M ﹤0.01% 1817
2023
Q2 		– Sell
-13,900
Closed -$212K – 4021
2023
Q1 		$212K Sell
13,900
-201,267
-94% -$2.62M ﹤0.01% 3253
2022
Q4 		$2.74M Sell
215,167
-18,600
-8% -$167K ﹤0.01% 1885
2022
Q3 		$1.35M Sell
233,767
-71,100
-23% -$312K ﹤0.01% 2302
2022
Q2 		$982K Buy
304,867
+41,467
+16% +$125K ﹤0.01% 2737
2022
Q1 		$993K Buy
+263,400
New +$1.7M ﹤0.01% 2731
2021
Q1 		– Sell
-37,230
Closed -$907K – 3427
2020
Q4 		$907K Buy
+37,230
New +$952K ﹤0.01% 2551

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Renaissance Technologies's ETNB Position: Q4 2025 in Review

Renaissance Technologies sold out of 89bio (ETNB) in Q4 2025, closing a stake of 510,500 shares — an estimated $7.5M sold.

Renaissance Technologies first reported a position in ETNB in Q4 2020 and held it in 12 quarters. The position peaked at $7.5M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Renaissance Technologies reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 510,500 89bio shares in Q4 2025, an estimated $7.5M.
  • Renaissance Technologies first reported a position in 89bio in Q4 2020 and held it in 12 quarters.
  • Renaissance Technologies's 89bio position peaked at $7.5M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.